Retrospective analysis of invasive fungal infection in surgical intensive care unit

National Medical Journal of China

Volumn 90, Issue 6, 2010, Pages 382-385

  Li, Shu ^a   An, You Zhong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Intensive care units; Mycoses

Indexed keywords

ARTICLE; ASPERGILLUS; ASSISTED VENTILATION; BACTERIAL INFECTION; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CATHETER INFECTION; FUNGEMIA; HUMAN; INTENSIVE CARE UNIT; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MIXED INFECTION; MORBIDITY; MORTALITY; NONHUMAN; RETROSPECTIVE STUDY; SYSTEMIC MYCOSIS; TRICHOSPORON; URINARY TRACT INFECTION; CROSS INFECTION; INCIDENCE; RISK FACTOR; STATISTICS;

CROSS INFECTION; FUNGEMIA; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84871441095     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.06.007     Document Type: Article

References (17)

1. 2007, 87: 2991-2993.
2. Vardakas K Z, Michalopoulos A, Kiriakidou K G, et al. Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients. Clin Microbiol Infect, 2009, 15: 289-292.
3. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis, 2003, 3: 685-702.
4. Leroy O, Gangneux J P, Montravers P, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med, 2009, 37: 1612-1618.
5. 2007, 46: 960-966.
6. Pittet D, Monod M, Suter P M, et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg, 1994, 220: 751-758.
7. 2008, 36: 31-33.
8. Voss A, Kluytmans J A, Koeleman L, et al. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis, 2006, 15: 909-912.
9. Marchetti O J, Bille U, Fluckiger P, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis, 2004, 38: 311-320.
10. 2004, 14: 1004-1005.
11. Vardakas K Z, Michalopoulos A, Kiriakidou K G, et al. Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients. Clin Microbiol Infect, 2009, 15: 289-292.
12. Segal B H. Aspergillosis. N Engl J Med, 2009, 360: 1870-1884.
13. Caston-Osorio J J, Rivero A, Torre-Cisneros J. Epidemiology of invasive fungal infection. Int J Antimicrob Agents, 2008, 32 Suppl 2: S103-S109.
14. Satwani P, Baldinger L. Incidence of viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant, 2009, 15: 1587-1595.
15. O'grady N P, Alexander M, Dellinger E P, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control, 2002, 30: 476-489.
16. Magill S S, Swoboda S M, Shields C E, et al. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. Ann Surg, 2009, 249: 657-659.
17. Garey K W, Rege M, Pai M P, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis, 2006, 43: 25-31.